Digital Pathology Software Improves Workflow Efficiency
|
By MedImaging International staff writers Posted on 31 Jan 2019 |

Image: uPath enterprise software provides improved digital pathology tools (Photo courtesy of Roche).
A novel software platform drastically decreases image-rendering times, integrates automated image analysis, and enables improved case sharing between pathologists.
The Roche (Basel, Switzerland) uPath enterprise software for digital pathology can help pathologists diagnose a patient case more quickly by viewing all slides in a single continuous view, as well as viewing all available patient information simultaneously. The multiple slides, which are presented on a canvas-like display, enabling seamless navigation between hematoxylin and eosin (HE), immunohistochemistry (IHC) and special stains in a single view, thanks to Leeds Virtual Microscope (LVM) technology, which is not possible with a standard microscope.
Analyses, both automated and manual, and slide markups are easily managed in the multi-slide viewer, while reporting features allow pathologists to aggregate notes, measurements, and slide scoring into easy-to-share images or PDFs. The customization offered through the uPath configurable interface and scalability allows pathologists to request second opinions and share cases in a fraction of the time that has traditionally been required, with no geographical limitations, unlike glass slides. LVM technology can also scale to display sizes ranging from laptops to high-definition wall screens.
"With this launch, we are able to deliver an improved digital pathology experience. We're excited to offer pathology labs a high-quality solution to help improve workflow efficiencies, accuracy, and precision tools,” said Jill German, Head of Roche Tissue Diagnostics. “This launch is another major milestone in our commitment to the advancement of patient care through digital pathology, empowering pathologists to deliver next-level personalized healthcare solutions.”
Digital pathology is an image-based information environment, which is enabled by computer technology, allowing for management of information generated from a digital slide. It is enabled in part by virtual microscopy, the conversion of glass slides into digital slides that can be viewed, managed, shared, and analyzed on a computer monitor. With the advent of whole-slide imaging, digital pathology is currently regarded as one of the most promising avenues of diagnostic medicine.
The Roche (Basel, Switzerland) uPath enterprise software for digital pathology can help pathologists diagnose a patient case more quickly by viewing all slides in a single continuous view, as well as viewing all available patient information simultaneously. The multiple slides, which are presented on a canvas-like display, enabling seamless navigation between hematoxylin and eosin (HE), immunohistochemistry (IHC) and special stains in a single view, thanks to Leeds Virtual Microscope (LVM) technology, which is not possible with a standard microscope.
Analyses, both automated and manual, and slide markups are easily managed in the multi-slide viewer, while reporting features allow pathologists to aggregate notes, measurements, and slide scoring into easy-to-share images or PDFs. The customization offered through the uPath configurable interface and scalability allows pathologists to request second opinions and share cases in a fraction of the time that has traditionally been required, with no geographical limitations, unlike glass slides. LVM technology can also scale to display sizes ranging from laptops to high-definition wall screens.
"With this launch, we are able to deliver an improved digital pathology experience. We're excited to offer pathology labs a high-quality solution to help improve workflow efficiencies, accuracy, and precision tools,” said Jill German, Head of Roche Tissue Diagnostics. “This launch is another major milestone in our commitment to the advancement of patient care through digital pathology, empowering pathologists to deliver next-level personalized healthcare solutions.”
Digital pathology is an image-based information environment, which is enabled by computer technology, allowing for management of information generated from a digital slide. It is enabled in part by virtual microscopy, the conversion of glass slides into digital slides that can be viewed, managed, shared, and analyzed on a computer monitor. With the advent of whole-slide imaging, digital pathology is currently regarded as one of the most promising avenues of diagnostic medicine.
Latest Imaging IT News
- Interactive AI Tool Supports Explainable Lung Nodule Assessment
- Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
Channels
Radiography
view channel
Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery
Obstructive ventilatory disorder, marked by airflow limitation that reduces breathing efficiency, increases postoperative risk in patients with lung cancer. Although surgery offers the best chance of cure,... Read more
AI Detection Tool Improves Identification of Lobular Breast Cancer
Breast cancer screening seeks early detection, yet some subtypes remain difficult to visualize on mammography, risking delayed diagnosis. On average, 1 in 20 women worldwide will develop breast cancer,... Read moreMRI
view channel
AI Body Composition MRI Analysis Predicts Cardiometabolic Disease Risk
Cardiometabolic disease, driven by interactions between cardiovascular and metabolic systems, is a leading cause of morbidity and mortality. Risk assessment often relies on body mass index, which overlooks... Read more
Blood-Brain Barrier Imaging Adds Risk Insight to Standard Stroke MRI
Acute ischemic stroke requires fast, precise decisions on reperfusion and bleeding risk, yet routine imaging gives limited insight into vascular integrity. Clinicians need ways to predict outcomes and... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channelMR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
Cardiac electrophysiology procedures are typically guided by X-ray fluoroscopy, which limits soft-tissue visualization and exposes patients and clinical staff to ionizing radiation. Real-time mapping that... Read more
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
New Proton Therapy Platform Integrates into Existing Radiotherapy Departments
Mevion Medical Systems (Littleton, MA, USA) has introduced the MEVION S250-FIT Proton Therapy System to the European radiation oncology community at ESTRO 2026, the first proton therapy platform designed... Read more
3D-Printed Intraoral Device Enhances Head and Neck Radiotherapy Accuracy
Ensuring consistent immobilization and soft-tissue positioning is central to safe, effective head and neck radiotherapy, where protection of organs at risk must be balanced with dose accuracy.... Read more
Molecular Imaging Agent Shows Promise for Endometriosis Detection and Monitoring
Diagnosing endometriosis remains challenging, particularly for superficial peritoneal endometriosis, the most common subtype, which is often missed on conventional imaging and typically requires laparoscopic... Read moreIndustry News
view channel
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







